Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab
Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · E36
DOI: 10.3816/clm.2009.n.098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von William Wierda und 19 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Wierda, W., Kipps, T., Mayer, J., Stilgenbauer, S., Williams, C. D., Hellmann, A., Robak, T., Furman, R. R., Hillmen, P., Trneny, M., Dyer, M. J., Padmanabhan, S., Piotrowska, M., Kozak, T., Chan, G., Davis, R., Losic, N., Wilms, J., Russell, C., & Österborg, A. (2009). Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab. Clinical Lymphoma and Myeloma, 9(6), E36. https://doi.org/10.3816/clm.2009.n.098
Vancouver
Wierda W, Kipps T, Mayer J, Stilgenbauer S, Williams CD, Hellmann A, et al. Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab. Clinical Lymphoma and Myeloma. 2009;9(6):E36. doi:10.3816/clm.2009.n.098
BibTeX
@article{Wierda2009,
author = {Wierda, William and Kipps, Thomas and Mayer, Jiří and Stilgenbauer, Stephan and Williams, Cathy D. and Hellmann, Andrzej and Robak, Tadeusz and Furman, Richard R. and Hillmen, Peter and Trneny, Marek and Dyer, Martin J.S. and Padmanabhan, Swami and Piotrowska, Magdalena and Kozak, Tomas and Chan, Geoffrey and Davis, Randy and Losic, Nedjad and Wilms, Joris and Russell, Charlotte and Österborg, Anders},
title = {Ofatumumab, a Novel CD20 Monoclonal Antibody, Is Active in Patients With Fludarabine- and Alemtuzumab-Refractory or Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia Irrespective of Prior Rituximab},
journal = {Clinical Lymphoma and Myeloma},
year = {2009},
volume = {9},
number = {6},
pages = {E36},
doi = {10.3816/clm.2009.n.098}
}
EUVIMED